Published in Hypertension on May 01, 1999
Angiotensin converting enzyme insertion/deletion genotype is associated with leukoaraiosis in lacunar syndromes. J Neurol Neurosurg Psychiatry (2002) 1.47
A study of gene--environment interaction on the gene for angiotensin converting enzyme: a combined functional and population based approach. J Med Genet (2004) 0.85
Gene by smoking interaction in hypertension: identification of a major quantitative trait locus on chromosome 15q for systolic blood pressure in Mexican-Americans. J Hypertens (2009) 0.84
ACE genotype may have an effect on single versus multiple set preferences in strength training. Eur J Appl Physiol (2005) 0.79
DD ACE gene polymorphism is associated with increased coronary artery endothelial dysfunction: the PREFACE trial. Heart (2003) 0.79
IgE-Mediated Anaphylaxis to Foods, Venom, and Drugs: Influence of Serum Angiotensin Converting Enzyme Levels and Genotype. J Allergy (Cairo) (2012) 0.76
Angiotensin-converting enzyme gene insertion/deletion polymorphism in Korean patients with systemic sclerosis. J Korean Med Sci (2006) 0.76
Renin-angiotensin system gene polymorphisms among Saudi patients with coronary artery disease. J Biol Res (Thessalon) (2014) 0.75
ACE-gene polymorphism and endothelial dysfunction in normal humans. Hypertension (1999) 0.75
Echocardiography in chronic heart failure in the community. Q J Med (1993) 7.64
Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet (1997) 6.48
QT dispersion and sudden unexpected death in chronic heart failure. Lancet (1994) 4.17
Association of road-traffic accidents with benzodiazepine use. Lancet (1998) 4.01
Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia (2006) 3.94
Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. Diabet Med (2002) 3.90
Investigation in general practice of patients with suspected heart failure. How should the essential echocardiographic service be delivered? Br Heart J (1995) 3.86
Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet (1996) 3.77
Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med (2008) 2.85
Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart (2002) 2.83
Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet Med (2005) 2.78
Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol (2000) 2.71
Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension (2000) 2.55
The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics (1997) 2.55
Socio-economic status, obesity and prevalence of Type 1 and Type 2 diabetes mellitus. Diabet Med (2000) 2.50
Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease. BMJ (1996) 2.43
Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods. Br Heart J (1994) 2.32
Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme. Diabetologia (2013) 2.31
Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction. Lancet (1993) 2.30
The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia (2010) 2.26
Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study. Clin Pharmacol Ther (2010) 2.22
Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes database. BMJ (1999) 2.14
Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia (2011) 2.12
Left ventricular hypertrophy: reduction of blood pressure already in the normal range further regresses left ventricular mass. Heart (2009) 2.12
Task-based learning: the answer to integration and problem-based learning in the clinical years. Med Educ (2000) 2.10
Further defining the role for natriuretic peptide levels in clinical practice. Eur Heart J (1999) 2.06
Urate predicts subsequent cardiac death in stroke survivors. Eur Heart J (2002) 2.02
Cloning of a human liver microsomal UDP-glucuronosyltransferase cDNA. Biochem J (1987) 1.97
Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. QJM (2007) 1.90
Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Eur J Clin Pharmacol (1989) 1.88
Glaucoma incidence in an unselected cohort of diabetic patients: is diabetes mellitus a risk factor for glaucoma? DARTS/MEMO collaboration. Diabetes Audit and Research in Tayside Study. Medicines Monitoring Unit. Br J Ophthalmol (2000) 1.85
Effect of intravenous adrenaline on electrocardiogram, blood pressure, and serum potassium. Br Heart J (1983) 1.79
The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J Biol Chem (2000) 1.76
Implementation of national diabetes retinal screening programme is associated with a lower proportion of patients referred to ophthalmology. Diabet Med (2005) 1.75
Contraindications to metformin therapy in patients with Type 2 diabetes--a population-based study of adherence to prescribing guidelines. Diabet Med (2001) 1.71
Adverse cardiac effects of salt with fludrocortisone in hypertension. Hypertension (2001) 1.70
Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. Circulation (2000) 1.70
Investigation in general practice of patients with suspected heart failure: how should the essential echocardiographic service be delivered? Br J Gen Pract (1995) 1.63
Aldosterone blunts the baroreflex response in man. Clin Sci (Lond) (1998) 1.60
A comparison between B-type natriuretic peptide, global registry of acute coronary events (GRACE) score and their combination in ACS risk stratification. Heart (2009) 1.59
QT dispersion in essential hypertension. QJM (1995) 1.57
Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol (1996) 1.56
A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer (2009) 1.56
The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Res Commun (1995) 1.56
The effects of cardioselective and non-selective beta-adrenoceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man. Clin Sci (Lond) (1983) 1.56
Enalapril reduces QTc dispersion in mild congestive heart failure secondary to coronary artery disease. Am J Cardiol (1997) 1.55
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
A new microtechnique for the analysis of the human hepatic microsomal glucose-6-phosphatase system. Clin Chim Acta (1988) 1.53
Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer (2005) 1.52
Should diabetic patients be screened for glaucoma? DARTS/MEMO Collaboration. Br J Ophthalmol (1999) 1.49
The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes. Mol Pharmacol (1988) 1.49
ABC of arterial and venous disease: vascular complications of diabetes. BMJ (2000) 1.49
ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. Biochem J (1997) 1.44
QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study. BMJ (1998) 1.41
How to use natriuretic peptide levels for diagnosis and prognosis. Eur Heart J (1999) 1.41
Effectiveness of captopril in reversing renal vasoconstriction after Q-wave acute myocardial infarction. Am J Cardiol (1993) 1.40
UDP-glucuronosyltransferases: a family of detoxifying enzymes. Trends Pharmacol Sci (1990) 1.39
Raised plasma concentrations of brain natriuretic peptide in pulmonary arterial hypertension. Respir Med (1995) 1.39
Heart failure: a diagnostic and therapeutic dilemma in elderly patients. Age Ageing (1998) 1.38
Implementing a national quality assurance system for diabetes care: the Scottish Diabetes Survey 2001-2006. Diabet Med (2008) 1.37
Extensive bilateral leg ulceration. Clin Exp Dermatol (2012) 1.37
Studies on the purification of rat liver uridine diphosphate glucuronyltransferase. Biochem J (1977) 1.35
Cloning and functional expression of an apparent splice variant of the murine 5-HT3 receptor A subunit. Eur J Pharmacol (1993) 1.34
Technical report: quantitative assessment of diaphragmatic movement--a reproducible method using ultrasound. Clin Radiol (1992) 1.30
Which drugs benefit diabetic patients for secondary prevention of myocardial infarction? DARTS/MEMO Collaboration. Diabet Med (1998) 1.29
Systemic beta-adrenoceptor responses to salbutamol given by metered-dose inhaler alone and with pear shaped spacer attachment: comparison of electrocardiographic, hypokalaemic and haemodynamic effects. Br J Clin Pharmacol (1989) 1.29
The effect of obesity on glycaemic response to metformin or sulphonylureas in Type 2 diabetes. Diabet Med (2006) 1.26
Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure. Heart (2005) 1.26
Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. Cardiovasc Res (1997) 1.24
Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes. Diabetologia (2008) 1.23
A national retinal screening programme for diabetes in Scotland. Diabet Med (2003) 1.22
Is there equity of service delivery and intermediate outcomes in South Asians with type 2 diabetes? Analysis of DARTS database and summary of UK publications. J Public Health (Oxf) (2009) 1.22
Sex differences in hypokalaemic and electrocardiographic effects of inhaled terbutaline. Thorax (1992) 1.21
TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels. Diabetologia (2007) 1.21
Prevalence and aetiology of hypothyroidism in the young. Arch Dis Child (2000) 1.21
How reproducible is bilateral forearm plethysmography? Br J Clin Pharmacol (1998) 1.21
Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics. Am Rev Respir Dis (1989) 1.20
Hospitalizations for people with type 1 and type 2 diabetes compared with the nondiabetic population of Tayside, Scotland: a retrospective cohort study of resource use. Diabetes Care (2000) 1.20
Development of phenobarbital-sensitive control mechanisms for uridine diphosphate glucuronyltransferase activity in chick embryo liver. J Cell Biol (1972) 1.18
Mortality and vascular outcomes in patients treated for thyroid dysfunction. J Clin Endocrinol Metab (2006) 1.18
A randomized control trial of the effect of negotiated telephone support on glycaemic control in young people with Type 1 diabetes. Diabet Med (2002) 1.18
Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes. Diabetologia (2004) 1.18
Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells. Proc Natl Acad Sci U S A (1988) 1.16
Human calcitonin gene related peptide: a potent endogenous vasodilator in man. Clin Sci (Lond) (1986) 1.15
Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS). Clin Endocrinol (Oxf) (2007) 1.14
Prior thiazide diuretic treatment increases adrenaline-induced hypokalaemia. Lancet (1983) 1.14
Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias. Clin Chim Acta (1997) 1.14
Substrate specificity and properties of uridine diphosphate glucuronyltransferase purified to apparent homogeneity from phenobarbital-treated rat liver. Biochem J (1978) 1.14
Abnormal myocardial repolarisation in response to hypoxaemia and fenoterol. Thorax (1995) 1.14
Dietary sodium restriction impairs insulin sensitivity in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1998) 1.14
UDP-glucuronosyltransferase activities. Guidelines for consistent interim terminology and assay conditions. Biochem Pharmacol (1983) 1.14
More than skin deep: atherosclerosis as a systemic manifestation of psoriasis. Br J Dermatol (2009) 1.13
Stratification of foot ulcer risk in patients with diabetes: a population-based study. Int J Clin Pract (2006) 1.13
The role of adrenal medullary catecholamines in potassium homoeostasis. Clin Sci (Lond) (1984) 1.13
A 12-year follow-up study of all-cause and cardiovascular mortality among 10,532 people newly diagnosed with Type 2 diabetes in Tayside, Scotland. Diabet Med (2010) 1.13